Biotechnology and Medical Research (TRBC)

Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict

Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict

Published 17/02/2018

The logo of Gilead Sciences Inc is pictured during a news conference in New Delhi September 15, 2014. REUTERS/Anindito Mukherjee/File Photo(Reuters) - A federal judge [more…]

Shares of Apricus tank after FDA declines to OK erectile…

Shares of Apricus tank after FDA declines to OK erectile…

Published 16/02/2018

FILE PHOTO: - A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo(Reuters) - [more…]

Apricus says FDA declines to approve erectile dysfunction cream

Apricus says FDA declines to approve erectile dysfunction cream

Published 16/02/2018

FILE PHOTO: - A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo(Reuters) - [more…]

Pot Pharm: Booming Canada weed sector plots next-wave medicines

Pot Pharm: Booming Canada weed sector plots next-wave medicines

Published 16/02/2018

A worker collects cuttings from a marijuana plant at the Canopy Growth Corporation facility in Smiths Falls, Ontario, Canada, January 4, 2018. REUTERS/Chris WattieTORONTO (Reuters) [more…]

U.S. FDA looks to pave way for earlier-stage Alzheimer’s drugs

U.S. FDA looks to pave way for earlier-stage Alzheimer’s drugs

Published 15/02/2018

FILE PHOTO - A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo(Reuters) - [more…]

Investors withdraw record $23.9 billion from U.S.-based stock funds: L

Investors withdraw record $23.9 billion from U.S.-based stock funds: L

Published 09/02/2018

Traders work on the floor of the New York Stock Exchange, (NYSE) in New York, U.S., February 6, 2018. REUTERS/Brendan McDermidNEW YORK (Reuters) - U.S. [more…]

New York accuses Insys of deceptively marketing opioid

New York accuses Insys of deceptively marketing opioid

Published 02/02/2018

FILE PHOTO: A box of the Fentanyl-based drug Subsys, made by Insys Therapeutics Inc, appears in an undated photograph provided by the U.S. Attorney's Office [more…]

AstraZeneca is sued by Array BioPharma over cancer drug royalties

AstraZeneca is sued by Array BioPharma over cancer drug royalties

Published 02/02/2018

NEW YORK (Reuters) - Array BioPharma Inc on Thursday sued AstraZeneca AB, accusing the pharmaceutical company of refusing to pay required royalties for a cancer [more…]

U.S. SEC files suit over possible insider trading on Bioverativ

U.S. SEC files suit over possible insider trading on Bioverativ

Published 27/01/2018

FILE PHOTO: The seal of the U.S. Securities and Exchange Commission hangs on the wall at SEC headquarters in Washington, DC, U.S., June 24, 2011. [more…]

U.S. tech stock funds attract most cash since 2000: Lipper

U.S. tech stock funds attract most cash since 2000: Lipper

Published 26/01/2018

NEW YORK (Reuters) - U.S. technology stock funds took in more cash in the week ended Jan. 24 than in any week since the turn-of-the-century [more…]